NewsBenzingaAttovia Therapeutics: l’EPS del terzo trimestre di $(0,76) non raggiunge la stima di $(0,50) Attovia Therapeutics: l’EPS del terzo trimestre di $(0,76) non raggiunge la stima di $(0,50) Benzinga 2026.11.09 21:51 (GMT+0) Open on Benzinga Other news Citigroup Maintains Buy on Kodiak AI, Lowers Price Target to $7 Swoosh and a Miss: Nike Investor Day Leaves Wall Street Cold-Footed Wall Street Says the AI Trade Is Over — ETF Investors Aren’t Acting Like It Citigroup Maintains Neutral on Westlake, Lowers Price Target to $65 Citigroup Maintains Neutral on LyondellBasell Industries, Lowers Price Target to $66 Caterpillar's 'Best-In-Class' Construction Business Is Getting Overlooked, Analyst Says